Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,401
archived clinical trials in
Alzheimer Disease

Effects of Aerobic Exercise for Treating Alzheimer's Disease
Aerobic Exercise in Alzheimer's Disease: Cognition and Hippocampal Volume Effects
Status: Enrolling
Updated:  12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Effects of Aerobic Exercise for Treating Alzheimer's Disease
Aerobic Exercise in Alzheimer's Disease: Cognition and Hippocampal Volume Effects
Status: Enrolling
Updated: 12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Enhancing Spatial Navigation Using Non-Invasive Brain Stimulation
Enhancing Spatial Navigation Using Non-Invasive Brain Stimulation
Status: Enrolling
Updated:  12/31/1969
Atlanta VA Medical and Rehab Center, Decatur, GA
mi
from
Decatur, GA
Enhancing Spatial Navigation Using Non-Invasive Brain Stimulation
Enhancing Spatial Navigation Using Non-Invasive Brain Stimulation
Status: Enrolling
Updated: 12/31/1969
Atlanta VA Medical and Rehab Center, Decatur, GA
mi
from
Decatur, GA
Click here to add this to my saved trials
Enhancing Spatial Navigation Using Non-Invasive Brain Stimulation
Enhancing Spatial Navigation Using Non-Invasive Brain Stimulation
Status: Enrolling
Updated:  12/31/1969
VA Ann Arbor Healthcare System, Ann Arbor, MI
mi
from
Ann Arbor, MI
Enhancing Spatial Navigation Using Non-Invasive Brain Stimulation
Enhancing Spatial Navigation Using Non-Invasive Brain Stimulation
Status: Enrolling
Updated: 12/31/1969
VA Ann Arbor Healthcare System, Ann Arbor, MI
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy Study of TPI-287 in Alzheimer's Disease
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Sequential Cohort, Dose-Ranging Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of TPI-287 in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
UCSF Memory and Aging Center
mi
from
San Francisco, CA
A Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy Study of TPI-287 in Alzheimer's Disease
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Sequential Cohort, Dose-Ranging Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of TPI-287 in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
UCSF Memory and Aging Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Markers of Alzheimers Disease and Cognitive Outcomes After Perioperative Care
Markers of Alzheimers Disease and Cognitive Outcomes After Perioperative Care
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Markers of Alzheimers Disease and Cognitive Outcomes After Perioperative Care
Markers of Alzheimers Disease and Cognitive Outcomes After Perioperative Care
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Alzheimer's Prevention Through Exercise
Effect of Aerobic Exercise on Pathophysiology of PreClinical Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
University of Kansas Medical Center
mi
from
Kansas City, KA
Alzheimer's Prevention Through Exercise
Effect of Aerobic Exercise on Pathophysiology of PreClinical Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Banner Alzheimer'S Institute
mi
from
Phoenix, AZ
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Banner Alzheimer'S Institute
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Four Peaks Neurology
mi
from
Scottsdale, AZ
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Four Peaks Neurology
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Banner Sun Health Research Institute
mi
from
Sun City, AZ
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Banner Sun Health Research Institute
mi
from
Sun City, AZ
Click here to add this to my saved trials
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
UC, Irvine
mi
from
Irvine, CA
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
UC, Irvine
mi
from
Irvine, CA
Click here to add this to my saved trials
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Hoag Memorial
mi
from
Newport Beach, CA
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Hoag Memorial
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Norther California PET Imaging Center
mi
from
Sacramento, CA
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Norther California PET Imaging Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
UC Davis
mi
from
Sacramento, CA
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
UC Davis
mi
from
Sacramento, CA
Click here to add this to my saved trials
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
UC San Francisco
mi
from
San Francisco, CA
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
UC San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Neurological Research Institute
mi
from
Santa Monica, CA
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Neurological Research Institute
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Molecular Neuroimaging, LLC
mi
from
New Haven, CT
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Molecular Neuroimaging, LLC
mi
from
New Haven, CT
Click here to add this to my saved trials
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Quantum Laboratories
mi
from
Deerfield Beach, FL
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Quantum Laboratories
mi
from
Deerfield Beach, FL
Click here to add this to my saved trials
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
21st Century Oncology
mi
from
Fort Myers, FL
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
21st Century Oncology
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Sandlake Imaging
mi
from
Orlando, FL
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Sandlake Imaging
mi
from
Orlando, FL
Click here to add this to my saved trials
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
USF Health Byrd Alzheimer's Center
mi
from
Tampa, FL
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
USF Health Byrd Alzheimer's Center
mi
from
Tampa, FL
Click here to add this to my saved trials
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Independent Imaging
mi
from
West Palm Beach, FL
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Independent Imaging
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Boston University
mi
from
Boston, MA
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Boston University
mi
from
Boston, MA
Click here to add this to my saved trials
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Alzheimer's Disease Center
mi
from
Quincy, MA
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Alzheimer's Disease Center
mi
from
Quincy, MA
Click here to add this to my saved trials
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Las Vegas Radiology
mi
from
Las Vegas, NV
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Las Vegas Radiology
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Center for Brain Health - NYU Langone Medical Center
mi
from
New York, NY
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Center for Brain Health - NYU Langone Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Rhode Island Hospital
mi
from
Providence, RI
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Butler Hospital
mi
from
Providence, RI
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Butler Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic
mi
from
Scottsdale, AZ
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Meridien Research
mi
from
Saint Petersburg, FL
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Meridien Research
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Center for Clinical Imaging Research
mi
from
Saint Louis, MO
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI and AD Subjects
An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects With Mild Cognitive Impairment, and Subjects With Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Center for Clinical Imaging Research
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Modulation of Micro-RNA Pathways by Gemfibrozil in Predementia Alzheimer Disease
Modulation of Micro-RNA Pathways by Gemfibrozil in Predementia Alzheimer Disease
Status: Enrolling
Updated:  12/31/1969
University of Kentucky
mi
from
Lexington, KY
Modulation of Micro-RNA Pathways by Gemfibrozil in Predementia Alzheimer Disease
Modulation of Micro-RNA Pathways by Gemfibrozil in Predementia Alzheimer Disease
Status: Enrolling
Updated: 12/31/1969
University of Kentucky
mi
from
Lexington, KY
Click here to add this to my saved trials
Exercise in Asymptomatic Pre-Alzheimer's Disease Pilot Study
Exercise in Asymptomatic Pre-Alzheimer's Disease Pilot Study/ 18F-AV-45-A14 - CLINICAL EVALUATION OF FLORBETAPIR F 18 (18F-AV-45) Sponsor of 18F-AV-45-A14: Avid Radiopharmaceuticals
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Florida
mi
from
Jacksonville, FL
Exercise in Asymptomatic Pre-Alzheimer's Disease Pilot Study
Exercise in Asymptomatic Pre-Alzheimer's Disease Pilot Study/ 18F-AV-45-A14 - CLINICAL EVALUATION OF FLORBETAPIR F 18 (18F-AV-45) Sponsor of 18F-AV-45-A14: Avid Radiopharmaceuticals
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Banner Sun Health Research Insitute
mi
from
Sun City, AZ
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Banner Sun Health Research Insitute
mi
from
Sun City, AZ
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
ATP Clinical Research, Inc.
mi
from
Costa Mesa, CA
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
ATP Clinical Research, Inc.
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Pacific Research Network - PRN
mi
from
San Diego, CA
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Pacific Research Network - PRN
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
California Neuroscience Research Medical Group, Inc
mi
from
Sherman Oaks, CA
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
California Neuroscience Research Medical Group, Inc
mi
from
Sherman Oaks, CA
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Meridien Research
mi
from
Brooksville, FL
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Meridien Research
mi
from
Brooksville, FL
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Brain Matters Research
mi
from
Delray Beach, FL
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Brain Matters Research
mi
from
Delray Beach, FL
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Alzheimer's Research and Treatment Center
mi
from
Lake Worth, FL
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Alzheimer's Research and Treatment Center
mi
from
Lake Worth, FL
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Miami Jewish Health Systems; Clinical Research
mi
from
Miami, FL
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Miami Jewish Health Systems; Clinical Research
mi
from
Miami, FL
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
University of South Florida
mi
from
Tampa, FL
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Pennington Biomedical Research Center
mi
from
Baton Rouge, LA
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Pennington Biomedical Research Center
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Louisiana Research Associates, Inc.
mi
from
New Orleans, LA
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Louisiana Research Associates, Inc.
mi
from
New Orleans, LA
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Ocean Rheumatology, PA
mi
from
Toms River, NJ
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Ocean Rheumatology, PA
mi
from
Toms River, NJ
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Nathan Kline Institute
mi
from
Orangeburg, NY
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Nathan Kline Institute
mi
from
Orangeburg, NY
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Richmond Behavioral Associates
mi
from
Staten Island, NY
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Richmond Behavioral Associates
mi
from
Staten Island, NY
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Alzheimer's Memory Center
mi
from
Charlotte, NC
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Alzheimer's Memory Center
mi
from
Charlotte, NC
Click here to add this to my saved trials